Benchmark Electronics (BHE) Q1 2026 earnings review
AI and Medical Drive The Beat While FY26 Outlook Accelerates
Benchmark delivered a strong Q1, exceeding expectations with 7.1% YoY revenue growth to $677M and raising its full-year growth outlook from mid-single digits to 9-10%. The narrative from new CEO David Moezidis focuses on a 'broad cross-section' of improvement, but the data reveals a dramatic mix shift: surging demand in AC&C (+42% YoY) and Medical (+23% YoY) completely masked YoY contractions in the Industrial and Aerospace & Defense (A&D) segments. With Semi-Cap showing early signs of a cyclical rebound, the company is exceptionally well-positioned for H2 2026, provided they can manage the significant step-up in capital expenditures required to fund this growth.
🐂 Bull Case
The AC&C segment has structurally transformed. Driven by liquid cooling infrastructure and Enterprise AI program wins, revenue jumped 42% YoY to $105M. This acts as a powerful new growth engine alongside traditional segments.
After bottoming at $171M in 25Q4, Semi-Cap revenue rebounded to $191M in 26Q1 (+12% QoQ). The aggressive facility expansions in Penang, Malaysia, are timed perfectly to capture this upcycle.
🐻 Bear Case
Capital expenditures surged to $18.3M in Q1, up more than 4x compared to $4.2M a year ago. Funding the new AI programs and Penang expansion is eating into free cash flow margins.
Despite management's claims of 'broad' improvement, the Industrial and A&D segments both shrank YoY in Q1. If defense program timing continues to slip, they will drag on the company's otherwise stellar growth rate.
⚖️ Verdict: 🟢
Bullish. The 42% surge in AC&C proves Benchmark is successfully monetizing the AI infrastructure wave. Raising annual guidance to 9-10% growth in Q1 demonstrates high visibility and immense confidence in the H2 order book.
Key Themes
Enterprise AI and Liquid Cooling Drive AC&C Surge
Accelerating. The Advanced Computing & Communications (AC&C) segment was previously a laggard but has violently reversed course. Revenue hit $105M, up 42% YoY. The company is actively capitalizing on its US-based liquid cooling infrastructure capabilities for Enterprise AI builds, shifting its profile from a traditional EMS provider to an AI infrastructure proxy.
Medical Segment's Multi-Quarter Inventory Hangover is Cured
Accelerating. Medical revenue came in at $128M, representing a 23% YoY increase. This definitively confirms that the massive customer inventory destocking phase seen in early 2025 is completely finished, and base business combined with new MedTech bookings is delivering sustainable double-digit growth.
Semi-Cap Cycle Bottoms Out
Reversing. Semiconductor Capital Equipment revenue grew 12% sequentially from 25Q4 ($171M to $191M). Management's prior quarter commentary cited 'mounting evidence' of an early 2026 demand inflection, and the Q1 data proves they called the exact bottom correctly. Expansion at their PT 4 facility in Penang positions them to absorb the upcoming volume surge.
Industrial and A&D Contradict the 'Broad Improvement' Narrative
Decelerating. CEO David Moezidis cited 'improvement across a broad cross-section of our business,' but the data does not support this universally. A&D revenue dropped 1.6% YoY to $120M, and Industrial dropped 2.9% YoY to $133M. While A&D weakness is tied to defense program timing, the industrial segment remains highly sensitive to macro pressures and is dragging down total top-line performance.
Capital Intensity Triples to Support Growth
Accelerating. Additions to PP&E and software (CapEx) jumped to $18.27M in Q1, up from $4.15M a year ago. While operating cash flow remains very healthy ($47M), the increased capital requirements to build liquid cooling infrastructure and outfit cleanrooms in Asia are taking a much larger bite out of free cash flow, which grew only modestly to $29M.
Macro Pressures: Tariffs and Trade Restrictions
Stable. The forward-looking statements continue to explicitly flag geopolitical uncertainties, tariffs, and potential U.S. government shutdowns. In prior quarters, tariff uncertainties elongated customer booking cycles. Furthermore, the pace of the Semi-Cap recovery remains structurally vulnerable to shifting U.S. trade restrictions on semiconductor equipment exports to China.
Sequential Margin Compression
Reversing. After finishing 25Q4 with a robust Non-GAAP Operating Margin of 5.5%, margins stepped backward to 4.8% in 26Q1. While some of this is standard Q1 seasonality, it is a key metric to monitor to ensure that the rapidly growing AI server and Medical device builds aren't diluting overall corporate profitability.
Other KPIs
Stable sequentially, but a massive improvement from 86 days in 25Q1. Benchmark's operational discipline is shining here. Days in inventory fell from 89 to 75 YoY, while days in accounts payable expanded favorably from 61 to 67. This working capital efficiency is the sole reason free cash flow remained positive despite surging capital expenditures.
Up slightly from $27 million in 25Q1. Operating cash flow grew an impressive 49% YoY to $47 million, heavily driven by favorable accounts payable timing. However, the bulk of this operating cash upside was consumed by the $18M CapEx bill. The company still generated enough cash to confidently execute $5.8M in share repurchases.
Guidance
Accelerating. The $720 million midpoint represents a massive 12.1% YoY growth rate compared to the $642 million generated in 25Q2. This signals immense confidence that the Semi-Cap and AI ramps are accelerating rapidly into the summer.
Accelerating. The midpoint of $0.68 represents a 23.6% YoY jump versus 25Q2's $0.55. Crucially, EPS is projected to grow nearly twice as fast as revenue, demonstrating strong operating leverage is returning to the model.
Accelerating. Upgraded from previous guidance of 'mid-single-digit growth.' This implies full-year revenue will crest $2.9 billion (up from $2.66 billion in FY25), driven almost entirely by the Semi-Cap recovery and the newly established Enterprise AI base.
Key Questions
Industrial and A&D Weakness
You noted a 'broad cross-section' of improvement, yet Industrial and A&D contracted YoY this quarter. Is this merely a timing issue of specific programs pushing to the right, or are you seeing genuine demand destruction in these end markets?
Margin Profile of Enterprise AI
With AC&C surging 42% YoY on the back of liquid cooling and AI infrastructure, can you speak to the margin profile of these new builds? Is this business accretive or dilutive to the corporate 10%+ gross margin target?
CapEx Normalization
CapEx more than quadrupled YoY to over $18M in Q1. Should investors view this as a new baseline run-rate to support higher 9-10% annual growth, or is there a specific bulge tied to the Penang facility that will taper off in the second half?